KR
55
2
DG
26
-2
DE
39
3
MNST
65
5
REGN
71
6
XEL
58
3
MPC
44
14
WM
70
2
NKE
42
2
SBUX
27
2
LRCX
59
6
EMR
39
2
CAH
40
-3
DGX
48
4
VRSK
66
7
KMX
49
2
AEP
56
3
MCO
74
4
TJX
64
2
GPS
57
5
KR
55
2
DG
26
-2
DE
39
3
MNST
65
5
REGN
71
6
XEL
58
3
MPC
44
14
WM
70
2
NKE
42
2
SBUX
27
2
LRCX
59
6
EMR
39
2
CAH
40
-3
DGX
48
4
VRSK
66
7
KMX
49
2
AEP
56
3
MCO
74
4
TJX
64
2
GPS
57
5
Financhill
Back

Biomarin Pharmaceutical Quote, Financials, Valuation and Earnings

Unlock the Secret to Earning Monthly Income!

Limited spots act swiftly
Buy
52

BMRN
Biomarin Pharmaceutical

Last Price:
82.47
Seasonality Move:
6.56%

7 Day Trial

ALL ACCESS PASS

$ 7

I love this overnight trade happening Thursday

Access my free presentation on these overnight trades right here

Biomarin Pharmaceutical Price Quote

$82.47
+0.03 (+-1.59%)
(Updated: May 4, 2024 at 6:10 AM ET)

Biomarin Pharmaceutical Key Stats

Buy
52
Biomarin Pharmaceutical (BMRN) is a Buy
Day range:
$82.32 - $84.80
52-week range:
$76.02 - $99.56
Dividend yield:
0%
P/E ratio:
94.76
P/S ratio:
6.45
P/B ratio:
3.09%
Volume:
1.6M
Avg. volume:
1.7M
1-year change:
-11.9%
Market cap:
$15.7B
Revenue:
$2.4B
EPS:
$1.07

How Much Does Biomarin Pharmaceutical Make?

Is Biomarin Pharmaceutical Growing As A Company?

Biomarin Pharmaceutical Stock Price Performance

What Is Biomarin Pharmaceutical 52-Week High & Low?

Biomarin Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Biomarin Pharmaceutical?

Is Biomarin Pharmaceutical Cash Flow Positive?

  • What Is BMRN Cash Flow From Operations?
    Cash flow from operations (TTM) is $280.2M
  • What Is Biomarin Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$20.8M
  • What Is Biomarin Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$95.5M

Biomarin Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    BMRN return on invested capital is 3.45%
  • What Is Biomarin Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 3.07%
  • What Is BMRN Return On Equity?
    ROE is a measure of profitability and is 4.22%

Biomarin Pharmaceutical Earnings Date & Stock Price

Biomarin Pharmaceutical Competitors

Biomarin Pharmaceutical Dividend Yield

Data Unavailable

Biomarin Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 70.37% 18.33%
Revenue: 8.79% -0.46%

Analyst Recommendations

Buy Recommendations: 14
Hold Recommendations: 9
Sell Recommendations: 0
Price Target: 110.02
Upside from Last Price: 33.45%

Major Shareholders

  • How many BMRN shares are owned by institutional investors?
    300.5M BMRN shares are owned by institutional investors
  • How many BMRN shares are owned by insiders?
    2.5M BMRN shares are owned by insiders